Search Results 2201-2210 of 2837 for site:slotspk17.com

  1. A Study of Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for Relapsed Multiple Myeloma - Mayo Clinic

    To determine the overall response rate with iberdomide, daratumumab, elotuzumab and dexamethasone (IberDEd) when used as therapy in patients with relapsed ...

  2. A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients - Mayo Clinic

    The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of study drug AJ201 in subjects with Spinal and Bulbar ...

  3. Study Of MRTX1133 In Patients With Advanced Solid Tumors Harboring A KRAS G12D Mutation - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Researchers make unexpected discovery in how pancreatic cancer spreads - Mayo Clinic News Network

    Gina Razidlo, Ph.D. Looking inside the tumor microenvironment. Tumors grow in nutrient-poor environments, so cancer cells must rewire cellular metabolism to ...

  5. Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy - Mayo Clinic

    Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy · Overview · Participation ...

  6. Evaluate the Safety and Efficacy of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery (ENCASE II) - Mayo Clinic

    The purpose of this study is to clinically assess the safety and effectiveness of LIQOSEAL® as a means of reducing intra-, as well as post-operative, CSF ...

  7. A Study to Evaluate Regorafenib with Cetuximab or Panitumumab to Treat Unresectable, Locally Advanced, or Metastatic Colorectal Cancer - Mayo Clinic

    Regorafenib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as cetuximab or panitumumab, ...

  8. Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason ...

  9. Celiac Disease Tissue Destruction and Healing - Mayo Clinic

    Additionally, to test the hypothesis that interactions between IECs, microbiota, immune system, genetics and gluten underlie differences in clinical ...

  10. Transforaminal Lumbar Interbody Fusion (TLIF) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...